237 related articles for article (PubMed ID: 20179184)
1. Use of chemotherapy for patients with bone and soft-tissue sarcomas.
Wesolowski R; Budd GT
Cleve Clin J Med; 2010 Mar; 77 Suppl 1():S23-6. PubMed ID: 20179184
[TBL] [Abstract][Full Text] [Related]
2. Appraising the current role of chemotherapy for the treatment of sarcoma.
D'Adamo DR
Semin Oncol; 2011 Oct; 38 Suppl 3():S19-29. PubMed ID: 22055968
[TBL] [Abstract][Full Text] [Related]
3. The evolution of chemotherapeutic agents for the treatment of pediatric musculoskeletal malignancies.
Velez-Yanguas MC; Warrier RP
Orthop Clin North Am; 1996 Jul; 27(3):545-9. PubMed ID: 8649735
[TBL] [Abstract][Full Text] [Related]
4. A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
Baruchel S; Pappo A; Krailo M; Baker KS; Wu B; Villaluna D; Lee-Scott M; Adamson PC; Blaney SM
Eur J Cancer; 2012 Mar; 48(4):579-85. PubMed ID: 22088484
[TBL] [Abstract][Full Text] [Related]
5. [Pre- and postoperative chemotherapy in bone and soft tissue tumors].
Höffken K
Langenbecks Arch Chir; 1987; 372():311-4. PubMed ID: 3481009
[TBL] [Abstract][Full Text] [Related]
6. Trabectedin: new drug. Soft-tissue sarcomas: too many adverse effects.
Prescrire Int; 2009 Aug; 18(102):161. PubMed ID: 19743575
[No Abstract] [Full Text] [Related]
7. Chemotherapy for Bone Sarcoma in Adults.
Wagner MJ; Livingston JA; Patel SR; Benjamin RS
J Oncol Pract; 2016 Mar; 12(3):208-16. PubMed ID: 26962160
[TBL] [Abstract][Full Text] [Related]
8. A role for maintenance therapy in managing sarcoma.
Ray-Coquard I; Le Cesne A
Cancer Treat Rev; 2012 Aug; 38(5):368-78. PubMed ID: 21843915
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant chemotherapy in the treatment of sarcomas].
Fayette J; Blay JY
Bull Cancer; 2006 Mar; 93(3):257-61. PubMed ID: 16567312
[TBL] [Abstract][Full Text] [Related]
10. Contemporary Therapy for Advanced Soft-Tissue Sarcomas in Adults: A Review.
Pang A; Carbini M; Maki RG
JAMA Oncol; 2016 Jul; 2(7):941-7. PubMed ID: 27148906
[TBL] [Abstract][Full Text] [Related]
11. Soft tissue and bone sarcomas.
Santoro A; Bonadonna G
Cancer Chemother Biol Response Modif; 1994; 15():620-7. PubMed ID: 7779603
[No Abstract] [Full Text] [Related]
12. Chemotherapeutic management of soft tissue sarcoma.
Thornton K
Surg Clin North Am; 2008 Jun; 88(3):647-60, viii. PubMed ID: 18514704
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
Scotlandi K; Perdichizzi S; Manara MC; Serra M; Benini S; Cerisano V; Strammiello R; Mercuri M; Reverter-Branchat G; Faircloth G; D'Incalci M; Picci P
Clin Cancer Res; 2002 Dec; 8(12):3893-903. PubMed ID: 12473605
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy in complex treatment of bone and soft tissue sarcomas.
Matĕjovský Z
Oncology; 1980; 37 Suppl 1():97-103. PubMed ID: 7005794
[No Abstract] [Full Text] [Related]
15. [Indication of chemotherapy according to histological type of musculoskeletal sarcomas].
Goto T; Okuma T; Ogura K; Imanishi J; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2009 Feb; 36(2):199-203. PubMed ID: 19223736
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
Schuetze SM
J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
[TBL] [Abstract][Full Text] [Related]
17. In brief: Two Drugs for soft-tissue sarcoma.
Med Lett Drugs Ther; 2016 May; 58(1494):e62. PubMed ID: 27148925
[No Abstract] [Full Text] [Related]
18. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
[TBL] [Abstract][Full Text] [Related]
19. The 'other' bone sarcomas in Japan: a retrospective study of primary bone sarcomas other than osteosarcoma, Ewing sarcoma and chondrosarcoma, using data from the Bone Tumuor Registry in Japan.
Nagano A; Tsugita M; Nishimoto Y; Akiyama H; Kawai A
Jpn J Clin Oncol; 2021 Aug; 51(9):1430-1436. PubMed ID: 34105731
[TBL] [Abstract][Full Text] [Related]
20. Major efficacy of trabectedin in 2 metastatic osteosarcoma patients with wild-type Asp1104 ERCC5 tumor status.
Gastaud L; Saâda-Bouzid E; Le Morvan V; Pourquier P; Ianessi A; Thariat J; Italiano A; Thyss A
Onkologie; 2013; 36(11):670-3. PubMed ID: 24192772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
